ZFIN ID: ZDB-PUB-120125-28
Target of rapamcyin (TOR)-based therapeutics for cardiomyopathy: Insights from zebrafish genetics
Ding, Y., Sun, X., Redfield, M., Kushwaha, S., and Xu, X.
Date: 2012
Source: Cell cycle (Georgetown, Tex.)   11(3): 428-429 (Other)
Registered Authors: Ding, Yonghe, Sun, Xiaojing, Xu, Xiaolei
Keywords: none
MeSH Terms:
  • Animals
  • Cardiomyopathies/drug therapy*
  • Cardiomyopathies/genetics
  • Mutation
  • Protein Kinase Inhibitors/pharmacology
  • Protein Kinase Inhibitors/therapeutic use*
  • Signal Transduction/drug effects
  • Sirolimus/pharmacology
  • Sirolimus/therapeutic use*
  • TOR Serine-Threonine Kinases/antagonists & inhibitors*
  • TOR Serine-Threonine Kinases/genetics
  • TOR Serine-Threonine Kinases/metabolism
  • Zebrafish/genetics*
PubMed: 22262179 Full text @ Cell Cycle
ABSTRACT
Comment on: Ding Y, et al. Circ Res 2011; 109:658-69.
ADDITIONAL INFORMATION No data available
ERRATA and NOTES
Editorial of: Ding Y, et al. Circ Res 2011; 109; 658-669